Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Livongo Health, Inc.    LVGO

LIVONGO HEALTH, INC.

(LVGO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization1 -2 3685 659--
Entreprise Value (EV)1 -1 9765 2895 3305 356
P/E ratio --23,2x-141x-224x113x
Yield -----
Capitalization / Revenue -13,9x18,8x12,0x8,21x
EV / Revenue -11,6x17,6x11,3x7,77x
EV / EBITDA --101x-508x284x87,3x
Cours sur Actif net -4,71x12,9x13,5x12,1x
Nbr of stocks (in thousands) -94 48297 817--
Reference price (USD) -25,157,957,957,9
Last update 06/28/201903/02/202005/22/202005/22/202005/07/2020
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: December 2018 2019 2020 2021 2022
Net sales1 68,4170300471689
EBITDA1 --19,6-10,418,861,4
Operating profit (EBIT)1 --60,0-52,0-36,210,2
Operating Margin --35,3%-17,3%-7,69%1,48%
Pre-Tax Profit (EBT)1 --56,3-46,5-31,757,8
Net income1 --55,0-46,5-31,757,8
Net margin --32,4%-15,5%-6,74%8,38%
EPS2 --1,08-0,41-0,260,51
Dividend per Share2 -----
Last update 06/28/201903/02/202005/07/202005/07/202005/07/2020
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt1 -----
Net Cash position1 -392370329303
Leverage (Debt / EBITDA) -20,0x35,5x-17,5x-4,94x
Free Cash Flow1 --61,4-37,1-26,6-
ROE (Net Profit / Equities) --9,27%-2,92%2,62%5,37%
Shareholders' equity1 -5931 594-1 2111 075
ROA (Net Profit / Asset) --5,20%-2,76%3,12%-
Assets1 -1 0581 687-1 016-
Book Value Per Share2 -5,324,494,304,79
Cash Flow per Share -----
Capex1 -2,001,002,555,00
Capex / Sales -1,17%0,33%0,54%0,73%
Last update 06/28/201903/02/202005/22/202005/22/202005/07/2020
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2020 S&P Global Market Intelligence
Key data
Capitalization (USD)
5 658 713 450
Net sales (USD)
169 853 000
Number of employees
671
Sales / Employee (USD)
253 134
Free-Float
91,6%
Free-Float capitalization (USD)
5 180 997 580
Avg. Exchange 20 sessions (USD)
183 827 163
Average Daily Capital Traded
3,25%
EPS & Dividend